Fundamentals and Applications of Controlled Release Drug Delivery
暂无分享,去创建一个
[1] Theresa M Allen,et al. Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. , 2002, Cancer research.
[2] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[3] K. Shakesheff,et al. Synthesis and Characterisation of a Degradable Poly(lactic acid)−Poly(ethylene glycol) Copolymer with Biotinylated End Groups , 2001 .
[4] Darrell M. Wilson,et al. A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.
[5] Mansoor Amiji,et al. Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells , 2008, The AAPS Journal.
[6] J. Hadgraft,et al. Modified-Release Drug Delivery Technology , 2002 .
[7] Joseph Kost,et al. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[8] C. Butts,et al. L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer , 2007, Clinical Cancer Research.
[9] X. Banquy,et al. Selectins ligand decorated drug carriers for activated endothelial cell targeting. , 2008, Bioconjugate chemistry.
[10] V. Lenaerts,et al. Degradation of poly (isobutyl cyanoacrylate) nanoparticles. , 1984, Biomaterials.
[11] C. Passirani,et al. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. , 1998, Life sciences.
[12] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[13] Y. Kawashima,et al. Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes , 1996, Pharmaceutical Research.
[14] V. Torchilin. Liposomes as delivery agents for medical imaging. , 1996, Molecular medicine today.
[15] Yan Zhang,et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[16] Jayanth Panyam,et al. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. , 2009, Biomaterials.
[17] Stavroula Sofou,et al. Antibody-targeted liposomes in cancer therapy and imaging , 2008, Expert opinion on drug delivery.
[18] P Couvreur,et al. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.
[19] Y. Kawashima,et al. Mucoadhesive nanoparticulate systems for peptide drug delivery. , 2001, Advanced drug delivery reviews.
[20] Vladimir P. Torchilin,et al. ATP-Loaded Liposomes Effectively Protect the Myocardium in Rabbits with an Acute Experimental Myocardial Infarction , 2005, Pharmaceutical Research.
[21] A. Hall,et al. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. , 1998, Science.
[22] Qiang Zhang,et al. Phospholipid deformable vesicles for buccal delivery of insulin. , 2002, Chemical & pharmaceutical bulletin.
[23] T. Park,et al. In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles , 2005, Journal of biomaterials science. Polymer edition.
[24] Jayanth Panyam,et al. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. , 2006, Journal of nanoscience and nanotechnology.
[25] H. Kolb,et al. The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.
[26] Y. Tseng,et al. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.
[27] Stavroula Sofou,et al. Surface-active liposomes for targeted cancer therapy. , 2007, Nanomedicine.
[28] J. Kreuter,et al. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] Martyn C. Davies,et al. Polystyrene-Poly (Ethylene Glycol) (PS-PEG2000) Particles as Model Systems for Site Specific Drug Delivery. 2. The Effect of PEG Surface Density on the in Vitro Cell Interaction and in VivoBiodistribution , 1994, Pharmaceutical Research.
[30] R. Desnick,et al. Enzyme therapy. VI: Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes. , 1977, Biochimica et biophysica acta.
[31] P. Couvreur,et al. Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models , 2007, Journal of drug targeting.
[32] M. Cotten,et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Couvreur,et al. Radical Emulsion Polymerization of Alkylcyanoacrylates Initiated by the Redox System Dextran-Cerium(IV) under Acidic Aqueous Conditions , 2003 .
[34] D Barry Keenan,et al. The pathway to the closed-loop artificial pancreas: research and commercial perspectives. , 2010, Pediatric endocrinology reviews : PER.
[35] R. Jain,et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.
[36] Z. Zhou,et al. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. , 2005, International journal of pharmaceutics.
[37] Eun Seong Lee,et al. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. , 2009, Molecular pharmaceutics.
[38] V. Torchilin,et al. ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[39] P. Couvreur,et al. In vitro model for the degradation of alkylcyanoacrylate nanoparticles. , 1990, Biomaterials.
[40] Rassoul Dinarvand,et al. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. , 2008, International journal of pharmaceutics.
[41] P. Couvreur,et al. Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis , 1991, Antimicrobial Agents and Chemotherapy.
[42] P. Couvreur,et al. Synthesis of Highly Functionalized Poly(alkyl cyanoacrylate) Nanoparticles by Means of Click Chemistry , 2008 .
[43] V. Torchilin,et al. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene , 2006, Journal of Controlled Release.
[44] Ying Sun,et al. Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma , 2010, Journal of materials science. Materials in medicine.
[45] Y. Schneider,et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[46] S. Grinstein,et al. CD44 is a phagocytic receptor. , 2006, Blood.
[47] H. Nishide,et al. Polymerized liposome as the carrier of heme. A physically stable oxygen carrier under physiological conditions. , 1985 .
[48] V. Pillay,et al. Drug delivery technologies for chronotherapeutic applications , 2009, Pharmaceutical development and technology.
[49] R. Bankert,et al. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. , 2000, Cancer research.
[50] K. Polonsky,et al. In vivo pulsatility of pancreatic islet peptides. , 1986, The American journal of physiology.
[51] Josep Vehí,et al. Combining Basal-Bolus Insulin Infusion for Tight Postprandial Glucose Control: An in Silico Evaluation in Adults, Children, and Adolescents , 2010, Journal of diabetes science and technology.
[52] R. Hermida,et al. Administration Time–Dependent Influence of Aspirin on Blood Pressure in Pregnant Women , 2003, Hypertension.
[53] E. Jubeli,et al. Synthesis, characterization, and molecular recognition of sugar‐functionalized nanoparticles prepared by a combination of ROP, ATRP, and click chemistry , 2010 .
[54] Hongzhe Sun,et al. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.
[55] V. Torchilin,et al. Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] A. Rawat,et al. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles , 2006, Journal of drug targeting (Print).
[57] G. Storm,et al. Immunoliposomes as Enzyme-Carriers (Immuno-Enzymosomes) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT): Optimization of Prodrug Activating Capacity , 1996, Pharmaceutical Research.
[58] A. Sabnis,et al. Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. , 2009, Journal of biomedical materials research. Part A.
[59] C. Allen,et al. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. , 2006, Bioconjugate chemistry.
[60] Adenosine triphosphate liposomes: encapsulation and distribution studies. , 1990, Pharmaceutical research.
[61] W. Waldhäusl,et al. Efficacy of Pulsatile Versus Continuous Insulin Administration on Hepatic Glucose Production and Glucose Utilization in Type I Diabetic Humans , 1986, Diabetes.
[62] V. Torchilin. Surface-modified liposomes in gamma- and MR-imaging , 1997 .
[63] Q. Shi,et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. , 2006, Biomaterials.
[64] M. Woodle,et al. Long Circulating Liposomes: Old Drugs, New Therapeutics , 1998, Biotechnology Intelligence Unit.
[65] J. Hanes,et al. Polymeric particles conjugated with a ligand to VCAM‐1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis , 2008, Biotechnology and bioengineering.
[66] T. Reynolds,et al. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[67] E. Haus. Chronobiology of Circulating Blood Cells and Platelets , 1992 .
[68] Hyun-chul Lee,et al. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. , 2005, International journal of pharmaceutics.
[69] M. Davies,et al. The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process , 1989 .
[70] R. Schiffelers,et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[71] J. Rothbard,et al. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. , 2004, Journal of the American Chemical Society.
[72] S. Davis,et al. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. , 2001, Biochimica et biophysica acta.
[73] Hatem Fessi,et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .
[74] M. Brandl,et al. Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes. , 1997, Investigative radiology.
[75] M. El-Samaligy,et al. Polyalkyl cyanoacrylate nanocapsules , 1986, The Journal of pharmacy and pharmacology.
[76] Zhirong Zhang,et al. Preparation and Characterization of a Novel Nonviral Gene Transfer System: Procationic-Liposome-Protamine-DNA Complexes , 2007, Drug delivery.
[77] P. Mallmann,et al. Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer , 2000, Anti-cancer drugs.
[78] Ching-Li Tseng,et al. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. , 2009, Biomaterials.
[79] Dae-Duk Kim,et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[80] Werner Tjarks,et al. A novel pH-sensitive liposome formulation containing oleyl alcohol. , 2002, Biochimica et biophysica acta.
[81] D. Tzemach,et al. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes , 1999, Cancer.
[82] Sérgio Simões,et al. On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.
[83] Nikhil Biswas,et al. Drug delivery system based on chronobiology--A review. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[84] G. Betageri,et al. Transdermal iontophoretic delivery of enkephalin formulated in liposomes. , 1996, Journal of pharmaceutical sciences.
[85] R. Gurny,et al. Aqueous nanodispersions prepared by a salting-out process , 1992 .
[86] N. Chiaramoni,et al. Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery , 2004, Drug delivery.
[87] M. Shoichet,et al. Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery , 2009 .
[88] M. Woodle,et al. Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.
[89] E. Schacht,et al. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. , 1998, Journal of pharmaceutical sciences.
[90] K. Velonia,et al. Click Chemistry: A Powerful Tool to Create Polymer‐Based Macromolecular Chimeras , 2008 .
[91] G. Paolisso,et al. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. , 1991, The Journal of clinical endocrinology and metabolism.
[92] Y. Kawashima,et al. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[93] Lawrence Mayer,et al. In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. , 2009, Leukemia research.
[94] R. Hintsche,et al. Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin , 2006, IEEE Transactions on Information Technology in Biomedicine.
[95] Xian‐Zheng Zhang,et al. Functionalized amphiphilic hyperbranched polymers for targeted drug delivery. , 2008, Biomacromolecules.
[96] V. Torchilin. Antibody-modified liposomes for cancer chemotherapy. , 2008, Expert Opinion on Drug Delivery.
[97] N. Konvalina,et al. Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. , 2011, Diabetes research and clinical practice.
[98] T. Allen,et al. Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 Epitopes , 2004, Clinical Cancer Research.
[99] R. Debs,et al. Cationic liposome-mediated gene delivery in vivo. , 2003, Methods in enzymology.
[100] Vladimir P Torchilin,et al. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.
[101] S. L. Bridal,et al. The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. , 2010, Biomaterials.
[102] T. Ravikumar,et al. Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes. , 1984, Surgery.
[103] Vladimir P Torchilin,et al. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[104] J. Poupaert,et al. Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers , 1993 .
[105] Wei-Chiang Shen,et al. Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives , 2007, Pharmaceutical Research.
[106] J. Nicolas,et al. Recent advances in the design of bioconjugates from controlled/living radical polymerization , 2010 .
[107] P. Speiser,et al. Nanoparticles--a new colloidal drug delivery system. , 1978, Pharmaceutica acta Helvetiae.
[108] F. Chang,et al. Sterically stabilized anti‐idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B‐cell lymphoma model , 1999, International journal of cancer.
[109] G. Halbert,et al. The in Vitro Cell Association of Invasin Coated Polylactide-Co-glycolide Nanoparticles , 2000, Pharmaceutical Research.
[110] Elias Fattal,et al. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. , 2007, International journal of pharmaceutics.
[111] R. Gurny,et al. Biodegradable nanoparticles for direct or two-step tumor immunotargeting. , 2006, Bioconjugate chemistry.
[112] P. Couvreur,et al. Design of folic acid-conjugated nanoparticles for drug targeting. , 2000, Journal of pharmaceutical sciences.
[113] E. Estey,et al. Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series , 2006, Leukemia & lymphoma.
[114] Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors. , 2001, Life sciences.
[115] D. Sørensen,et al. Cationic liposome-mediated delivery of siRNAs in adult mice. , 2003, Biochemical and biophysical research communications.
[116] Douglas J. Goetz,et al. Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.
[117] Eun Seong Lee,et al. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. , 2008, Small.
[118] Robert Langer,et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.
[119] Ming-Jium Shieh,et al. Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. , 2008, Biomaterials.
[120] M. Wilchek,et al. Introduction to avidin-biotin technology. , 1990, Methods in enzymology.
[121] Hatem Fessi,et al. Preparation and Characterization of Nanocapsules from Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique , 1998, Pharmaceutical Research.
[122] Babich,et al. Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. , 2000, Colloids and surfaces. B, Biointerfaces.
[123] Yoshioka Toshio,et al. Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatin , 1981 .
[124] Daniel A Hammer,et al. Quantifying nanoparticle adhesion mediated by specific molecular interactions. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[125] W. Chui,et al. Design of a Multifunctional PLGA Nanoparticulate Drug Delivery System: Evaluation of its Physicochemical Properties and Anticancer Activity to Malignant Cancer Cells , 2009, Pharmaceutical Research.
[126] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[127] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[128] Stanley J. Vernier,et al. Evaluating the Automated Blood Glucose Pattern Detection and Case-Retrieval Modules of the 4 Diabetes Support System® , 2010, Journal of diabetes science and technology.
[129] Nicholas A Peppas,et al. Stimuli-sensitive hydrogels: ideal carriers for chronobiology and chronotherapy , 2004, Journal of biomaterials science. Polymer edition.
[130] A. Mucci,et al. DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[131] M. G. Finn,et al. Click Chemistry: Diverse Chemical Function from a Few Good Reactions , 2001 .
[132] P. Couvreur,et al. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules. , 1986, Journal of pharmaceutical sciences.
[133] Y. Kato,et al. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[134] R. Gurny,et al. New approach for the preparation of nanoparticles by an emulsification-diffusion method , 1995 .
[135] S. Antimisiaris,et al. Liposomes for drug delivery to the lungs by nebulization. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[136] A. Kabanov,et al. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. , 1999, Bioconjugate chemistry.
[137] Sung‐Wook Choi,et al. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[138] V. Torchilin,et al. Protective Effect of Coenzyme Q10-loaded Liposomes on the Myocardium in Rabbits with an Acute Experimental Myocardial Infarction , 2007, Pharmaceutical Research.
[139] Q. Ping,et al. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. , 2004, Acta pharmacologica Sinica.
[140] H. Horinouchi,et al. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats* , 2004, Critical care medicine.
[141] V. Torchilin,et al. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.
[142] B. Smide,et al. Clarifying responsibility for self-management of diabetes in adolescents using insulin pumps--a qualitative study. , 2011, Journal of advanced nursing.
[143] R. Margalit,et al. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. , 1994, Archives of biochemistry and biophysics.
[144] Robert Gurny,et al. Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[145] Elias Fattal,et al. Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core as a Novel Colloidal Carrier for the Delivery of Oligonucleotides , 2000, Pharmaceutical Research.
[146] R. Gurny,et al. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size , 1992 .
[147] David A Jaffray,et al. Multimodal Contrast Agent for Combined Computed Tomography and Magnetic Resonance Imaging Applications , 2006, Investigative radiology.
[148] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[149] V. Lenaerts,et al. New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties. , 1989, Journal of pharmaceutical sciences.
[150] David A. Jaffray,et al. In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications , 2007, Pharmaceutical Research.
[151] Dae-Duk Kim,et al. Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability , 2007, Drug delivery.
[152] M A Vandelli,et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[153] M. Gnant,et al. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma , 2001, British Journal of Cancer.
[154] Jean-François Lutz,et al. 1,3-dipolar cycloadditions of azides and alkynes: a universal ligation tool in polymer and materials science. , 2007, Angewandte Chemie.
[155] Tae Gwan Park,et al. Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[156] Zhiyuan Hu,et al. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery. , 2008, Journal of biomedical materials research. Part A.
[157] Hua Ai,et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. , 2004, Angewandte Chemie.
[158] M. Trudel,et al. Virosome preparation: differences between influenza and rubella hemagglutinin adsorption. , 1981, Canadian journal of microbiology.
[159] Philip S Low,et al. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. , 2005, Journal of pharmaceutical sciences.
[160] A. Atkinson,et al. Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man. , 2003, Metabolism: clinical and experimental.
[161] M. Berger,et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[162] Joseph D. Andrade,et al. Protein—surface interactions in the presence of polyethylene oxide , 1991 .
[163] V. Torchilin. Polymeric contrast agents for medical imaging. , 2000, Current pharmaceutical biotechnology.
[164] Patrick Couvreur,et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. , 2005, Bioconjugate chemistry.
[165] P. Couvreur,et al. Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .
[166] C. Remuñán-López,et al. Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles , 1999, Pharmaceutical Research.
[167] H. J. Baker,et al. Enzyme replacement using liposome carriers in feline GM1 gangliosidosis fibroblasts , 1978, Nature.
[168] M. Peracchia. Stealth nanoparticles for intravenous administration , 2003 .
[169] E. K. Park,et al. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[170] E. Shusta,et al. Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.
[171] V. Torchilin,et al. TAT-liposomes: a novel intracellular drug carrier. , 2003, Current protein & peptide science.
[172] M. Nango,et al. Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[173] E. Fattal,et al. Quantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detector. , 2008, Journal of pharmaceutical and biomedical analysis.
[174] Jie Pan,et al. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. , 2008, Biomaterials.
[175] Lie Ma,et al. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting. , 2010, Journal of colloid and interface science.
[176] Jörg Huwyler,et al. Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney. , 2005, Journal of the American Society of Nephrology : JASN.
[177] Robert Langer,et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.
[178] J. Benoit,et al. Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[179] P Couvreur,et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. , 1999, Biomaterials.
[180] F. Szoka,et al. Comparative properties and methods of preparation of lipid vesicles (liposomes). , 1980, Annual review of biophysics and bioengineering.
[181] E Fattal,et al. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[182] S. Ohdo,et al. Molecular basis of chronopharmaceutics. , 2011, Journal of pharmaceutical sciences.
[183] Yuhan Lee,et al. Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel. , 2007, Biomacromolecules.
[184] R. Gurny,et al. Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[185] V. Torchilin,et al. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[186] D. Bazile,et al. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.
[187] R. Müller,et al. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.
[188] G. Tosi,et al. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[189] V. Torchilin,et al. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.
[190] T. K. Natarajan,et al. Albumin microspheres for study of the reticuloendothelial system. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[191] Janko Kos,et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[192] D. Scherman,et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[193] M Rabinovitch,et al. Professional and non-professional phagocytes: an introduction. , 1995, Trends in cell biology.
[194] You Han Bae,et al. Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[195] T. Young,et al. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. , 2007, Biomaterials.
[196] J. Mastrototaro,et al. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. , 2008, Diabetes technology & therapeutics.
[197] R. Schiffelers,et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.
[198] J. Kreuter,et al. In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.
[199] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[200] Johannes D Veldhuis,et al. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. , 2005, Diabetes.
[201] Y. M. Lee,et al. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. , 2001, Biomaterials.
[202] Robert Langer,et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.
[203] Christine Allen,et al. In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels , 2010, Pharmaceutical Research.
[204] A. Fahr,et al. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[205] E. C. van Winden. Freeze-drying of liposomes: theory and practice. , 2003, Methods in enzymology.
[206] H. Wagner,et al. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. , 1970, The International journal of applied radiation and isotopes.
[207] P. Couvreur,et al. Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles , 1994, Pharmaceutical Research.
[208] P. Couvreur,et al. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties , 1979, The Journal of pharmacy and pharmacology.
[209] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[210] Jinming Gao,et al. Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator FG020326. , 2008, Journal of biomedical materials research. Part A.
[211] Jeong Won Lee,et al. Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles , 2010, Clinical Cancer Research.
[212] P. Couvreur,et al. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. , 1993, Journal of biomedical materials research.
[213] Robert J. Lee,et al. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy. , 2003, Anticancer research.
[214] J Szebeni,et al. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. , 1999, Circulation.
[215] Q. Ping,et al. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. , 2008, International journal of pharmaceutics.
[216] M. Michaelis,et al. Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.
[217] P. Couvreur,et al. Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. , 1991, Journal of microencapsulation.
[218] H. Hauser,et al. Encapsulation of hemoglobin in phospholipid liposomes: characterization and stability. , 1985, Biochemistry.
[219] S. Lesieur,et al. Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. , 2007, International journal of pharmaceutics.
[220] R. Turner,et al. Pulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery , 1983, Diabetes.
[221] P. Artursson,et al. Characterization of polyacryl starch microparticles as carriers for proteins and drugs. , 1984, Journal of pharmaceutical sciences.
[222] C. Berkland,et al. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[223] G. Paolisso,et al. Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications , 1987, Diabetologia.
[224] Na Zhang,et al. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. , 2008, Bioconjugate chemistry.
[225] S. Sahoo,et al. Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer , 2004, International journal of cancer.
[226] S. Wagner,et al. Preparation and Evaluation of Lyophilized Iopromide‐Carrying Liposomes for Liver Tumor Detection , 1993, Investigative radiology.
[227] S. Krähenbühl,et al. Targeting of daunomycin using biotinylated immunoliposomes: Pharmacokinetics, tissue distribution and in vitro pharmacological effects , 2005, Journal of drug targeting.
[228] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[229] R. Gurny,et al. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.
[230] S. Sundar,et al. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[231] Z. Gu,et al. Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery , 2009, Journal of materials science. Materials in medicine.
[232] M. Madou,et al. Artificial Muscle Material with Fast Electroactuation under Neutral pH Conditions , 2004 .
[233] B. Engelhardt,et al. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.
[234] R. Lai,et al. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. , 2010, Biomaterials.
[235] S. Benita,et al. Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[236] L R Coney,et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.
[237] K. Strebhardt,et al. Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation. , 2008, Biomaterials.
[238] K. Ulbrich,et al. POLY(HPMA)-COATED LIPOSOMES DEMONSTRATE PROLONGED CIRCULATION IN MICE , 2001, Journal of liposome research.
[239] Wei Lu,et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[240] Sanyog Jain,et al. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. , 2004, International journal of pharmaceutics.
[241] S. Sahoo,et al. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. , 2005, Molecular pharmaceutics.
[242] M. Ogris,et al. Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. , 2003, International journal of pharmaceutics.
[243] P. Rutland,et al. Diurnal variation in the effects of insulin on blood glucose, plasma non-esterified fatty acids and growth hormone , 2004, Diabetologia.
[244] R. Rizza,et al. Differences Between Prebreakfast and Late Afternoon Glycemic Responses to Exercise in IDDM Patients , 1990, Diabetes Care.
[245] M. Trotta,et al. Nanoparticles from microemulsions , 1986 .
[246] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[247] C. Alving,et al. Complement-mediated acute effects of liposome-encapsulated hemoglobin. , 1999, Artificial cells, blood substitutes, and immobilization biotechnology.
[248] R. Hill,et al. Reconstitution of a porcine submaxillary gland beta-D-galactoside alpha 2----3 sialyltransferase into liposomes. , 1985, The Journal of biological chemistry.
[249] S. Kawakami,et al. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. , 2007, Biomaterials.
[250] Tae Gwan Park,et al. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[251] Kyung Chul Cho,et al. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[252] V. Labhasetwar,et al. Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.
[253] Francisco Orallo,et al. Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol , 2004, Pharmaceutical Research.
[254] I. Sjöholm,et al. Immobilization of proteins in microspheres of biodegradable polyacryldextran. , 1980, Journal of pharmaceutical sciences.
[255] Y. Eto,et al. Enzyme replacement with liposomes containing beta-galactosidase from Charonia lumpas in murine globoid cell leukodystrophy (twitcher). , 1985, Biochemical and biophysical research communications.
[256] J. Kreuter,et al. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[257] M. Zajac-Kaye,et al. DNAase I encapsulated in liposomes can induce neoplastic transformation of syrian hamster embryo cells in culture , 1984, Cell.
[258] Aliasger K Salem,et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[259] H. Uludaǧ,et al. Multifunctional Polymeric Micelles for Enhanced Intracellular Delivery of Doxorubicin to Metastatic Cancer Cells , 2008, Pharmaceutical Research.
[260] S. C. Baer,et al. Phagocytosis by zippers and triggers. , 1995, Trends in cell biology.
[261] R.S. Parker,et al. A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.
[262] G. Wood,et al. Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction , 2007, Biotechnology and bioengineering.
[263] D. Cavadore,et al. Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes , 1977, Diabetologia.
[264] Rajiv V Shah,et al. Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database. , 2010, Pediatric endocrinology reviews : PER.
[265] K. Skubitz. Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma* , 2003, Cancer investigation.
[266] M. Prabaharan,et al. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. , 2009, Biomaterials.
[267] A. Harken,et al. Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. , 1999, Circulation Research.
[268] Donald S. Coffey,et al. Identification and Characterization of Nuclease-stabilized RNA Molecules That Bind Human Prostate Cancer Cells via the Prostate-specific Membrane Antigen 1 , 2002 .
[269] V. Torchilin,et al. ATP-loaded immunoliposomes specific for cardiac myosin provide improved protection of the mechanical functions of myocardium from global ischemia in an isolated rat heart model , 2006, Journal of drug targeting.
[270] H. Uludaǧ,et al. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. , 2007, Biomacromolecules.
[271] John Walsh,et al. Guidelines for Insulin Dosing in Continuous Subcutaneous Insulin Infusion Using New Formulas from a Retrospective Study of Individuals with Optimal Glucose Levels , 2010, Journal of diabetes science and technology.
[272] Lin‐Yue Lanry Yung,et al. Selectivity of folate conjugated polymer micelles against different tumor cells. , 2008, International journal of pharmaceutics.
[273] R. Müller,et al. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.
[274] G. Khuller,et al. The protective efficacy of a liposomal encapsulated 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra tuberculosis in mice , 1997, Immunology and cell biology.
[275] R. Gurny,et al. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles. , 2007, International journal of pharmaceutics.
[276] Christine Jérôme,et al. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[277] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[278] C. Miller,et al. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.
[279] D. Bazile,et al. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. , 1996, Biomaterials.
[280] V. Torchilin. Liposomes as targetable drug carriers. , 1985, Critical reviews in therapeutic drug carrier systems.
[281] Jie Pan,et al. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers. , 2009, Biomaterials.
[282] Qiang Zhang,et al. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells , 2009, Journal of drug targeting.
[283] G. Schreiber,et al. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[284] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[285] Robert Sachsenhofer,et al. ′Click′ Chemistry in Polymer and Materials Science , 2007 .
[286] Robert Langer,et al. Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.
[287] Jean-Pierre Benoit,et al. Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.
[288] Xiaoling Zhang,et al. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[289] D. B. Keenan,et al. Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm , 2010, Journal of diabetes science and technology.
[290] V. Torchilin,et al. Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .
[291] P. Hildgen,et al. Functionalized nanospheres loaded with anti-angiogenic drugs: cellular uptake and angiosuppressive efficacy. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[292] M. Brewster,et al. Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621. , 2010, International journal of pharmaceutics.
[293] K. Anderson,et al. The potential of liposomes in oral drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.
[294] G. Zuccotti,et al. Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study. , 2011, Diabetes technology & therapeutics.
[295] P. Couvreur,et al. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading , 1990 .
[296] P. Rohdewald,et al. Interfacial Polymerization, A Useful Method for the Preparation of Polymethylcyanoacrylate Nanoparticles , 1986 .
[297] K. Pavey,et al. SPR analysis of the total reduction of protein adsorption to surfaces coated with mixtures of long- and short-chain polyethylene oxide block copolymers. , 1999, Biomaterials.
[298] Y. Chevalier,et al. Mechanism of nanocapsules formation by the emulsion-diffusion process. , 2008, Journal of colloid and interface science.
[299] D. Perrier,et al. Analysis of albumin microsphere preparation , 1984 .
[300] Fahima Dilnawaz,et al. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. , 2009, Biomaterials.
[301] Bruce Buckingham,et al. Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems. , 2010, Endocrinology and metabolism clinics of North America.
[302] J. Bancroft,et al. Perimenstrual Symptoms in Women with Diabetes Mellitus and the Relationship to Diabetic Control , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[303] Chulhee Kim,et al. Block Copolymer Micelles Conjugated with anti-EGFR Antibody for Targeted Delivery of Anticancer Drug , 2008 .
[304] Steven F Dowdy,et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.
[305] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[306] F. Behar-Cohen,et al. Oligonucleotide-Polyethylenimine Complexes Targeting Retinal Cells: Structural Analysis and Application to Anti-TGFβ-2 Therapy , 2006, Pharmaceutical Research.
[307] Y. Quinn,et al. New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. , 1999, Bioconjugate chemistry.
[308] H. Fessi,et al. [An original procedure for preparing nanocapsules of polyalkylcyanoacrylates for interfacial polymerization]. , 1986, Pharmaceutica acta Helvetiae.
[309] T. Tice,et al. Preparation of injectable controlled-release microcapsules by a solvent-evaporation process , 1985 .
[310] V. Torchilin,et al. Liposomes : a practical approach , 2003 .
[311] Si-Shen Feng,et al. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. , 2007, Biomaterials.
[312] Hong-Zhuan Chen,et al. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[313] R. Reilly,et al. Apoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy. , 2007, Molecular pharmaceutics.
[314] P Couvreur,et al. Development of a new drug carrier made from alginate. , 1993, Journal of pharmaceutical sciences.
[315] S. Sahu,et al. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery , 2010, Journal of materials science. Materials in medicine.
[316] A. Aderem,et al. Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.
[317] R. G. Anderson,et al. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway , 1990, The Journal of cell biology.
[318] P. Legrand,et al. Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. , 2000, Journal of pharmaceutical sciences.
[319] U. Matulonis,et al. A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer. , 2004, Gynecologic oncology.
[320] T. Park,et al. Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. , 2005, Macromolecular bioscience.
[321] P. Low,et al. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. , 2002, Biochimica et biophysica acta.
[322] R. Müller,et al. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. , 1992, Clinical nutrition.
[323] P. Couvreur,et al. PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases , 2001, Journal of Neuroscience Methods.
[324] J. Poupaert,et al. Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. , 1991, Journal of pharmaceutical sciences.
[325] Ruxandra Gref,et al. Polysaccharide-decorated nanoparticles. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[326] P. Artursson,et al. Identification of Cell Adhesion Molecules in the Human Follicle-Associated Epithelium That Improve Nanoparticle Uptake into the Peyer's Patches , 2006, Journal of Pharmacology and Experimental Therapeutics.
[327] J. Melnick,et al. Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes , 1980, Infection and immunity.
[328] S. Takeoka,et al. Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. , 2000, Bioconjugate chemistry.
[329] Sylvia Wagner,et al. Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. , 2008, Bioconjugate chemistry.
[330] M. Cima,et al. A controlled-release microchip , 1999, Nature.
[331] H. Kantarjian,et al. Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[332] J. Benoit,et al. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.
[333] J H Senior,et al. Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.
[334] G. Storm,et al. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of anticancer prodrugs , 1997 .
[335] M. Shoichet,et al. Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors. , 2009, Bioconjugate chemistry.
[336] Gareth Griffiths,et al. Lysosomal Enzyme Trafficking between Phagosomes, Endosomes, and Lysosomes in J774 Macrophages , 1998, The Journal of Biological Chemistry.
[337] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[338] M. Dewhirst,et al. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.
[339] K. Strebhardt,et al. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. , 2006, Biomaterials.
[340] E. Chang,et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. , 2002, Molecular cancer therapeutics.
[341] S. Kawakami,et al. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[342] E. Caron,et al. Molecular mechanisms of phagocytic uptake in mammalian cells , 2008, Cellular and Molecular Life Sciences.
[343] G. Birrenbach,et al. Polymerized micelles and their use as adjuvants in immunology. , 1976, Journal of pharmaceutical sciences.
[344] N. Berman,et al. A mathematical model of oscillatory insulin secretion. , 1993, The American journal of physiology.
[345] D F P Larkin,et al. Antibody targeted gene transfer to endothelium , 2003, The journal of gene medicine.